Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for Thrombocytopenia in Chronic Liver Disease Undergoing Elective Procedures
NCT07911800Phase 3Recruiting
- Sponsor
- Mibio Medical
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by Mibio Medical. Started Oct 2026; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07911800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911800.